US Patent Issued to Adaptive Biotechnologies on April 21 for "Methods of monitoring conditions by sequence analysis" (California Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,870, issued on April 21, was assigned to Adaptive Biotechnologies Corp. (Seattle).

"Methods of monitoring conditions by sequence analysis" was invented by Malek Faham (Pacifica, Calif.) and Thomas Willis (San Francisco).

According to the abstract* released by the U.S. Patent & Trademark Office: "There is a need for improved methods for determining the diagnosis and prognosis of patients with conditions, including autoimmune disease and cancer. Provided herein are methods for using DNA sequencing to identify personalized biomarkers in patients with autoimmune disease and other conditions. Identified biomarkers can be used to determine the disease state for a subject with an autoi...